{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.92A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "92"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001126112.3:c.158A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_001126112.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005211"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells stably overexpressing wild-type or mutant alpha-synuclein variants (A30P, A53T, E46K) were treated with rotenone and maneb."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.92A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "pathogenic",
          "Result Description": "Mutant A30P showed increased neuronal death under rotenone treatment."
        },
        {
          "Variant": "NM_001126112.3:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "pathogenic",
          "Result Description": "Mutant A53T exhibited enhanced aggregation under chronic maneb exposure."
        },
        {
          "Variant": "NM_001126112.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "pathogenic",
          "Result Description": "Mutant E46K demonstrated reduced cell viability in acute rotenone toxicity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Not specified in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein cells served as the positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated cells or vector-only controls were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with Tukey's post-hoc test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability > 85% under treatment conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 70% under treatment conditions.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}